Photo: Agencies

WASHINGTON, Oct. 2 (Xinhua) -- U.S. President Donald Trump is taking Remdesivir, a COVID-19 drug made by biopharmaceutical company Gilead Sciences, as a treatment, White House physician Sean Conley said on Friday.

Conley said in a memo that Trump, who is staying at Walter Reed National Military Medical Center in Bethesda, Maryland, "has completed his first dose and is resting comfortably."

The doctor said he recommended moving the president to Walter Reed on Friday afternoon "for further monitoring" in consultation with specialists from the military hospital and Johns Hopkins University.

"This evening I am happy to report that the President is doing very well," Conley continued. "He is not requiring any supplemental oxygen, but in consultation with specialists we have elected to initiate Remdesivir therapy."

"Going well, I think! Thank you to all. LOVE!!!" Trump tweeted from Walter Reed on Friday night.

The president tweeted early Friday morning that he and his wife, Melania, had tested positive for COVID-19 shortly after confirming a close aide to him had contracted the virus.